An interregional measles outbreak in Spain with nosocomial transmission, November 2017 to July 2018.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
04 2023
Historique:
medline: 1 5 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: ppublish

Résumé

Given sustained high vaccination coverage and enhanced surveillance for measles, Spain has been free of endemic measles transmission since 2014, achieving elimination certification from the World Health Organization in 2017. In November 2017, measles was introduced through an imported case travelling to the Valencian Community, causing an interregional outbreak. Here, we describe the outbreak using data reported to the national epidemiological surveillance network. The outbreak involved 154 cases (67 males, 87 females) notified in four regions; 148 were laboratory-confirmed and six epidemiologically linked. Most cases were adults aged 30-39 (n = 62, 40.3%) years. Sixty-two cases were hospitalised (40.3%) and 35 presented complications (22.7%). Two thirds of the cases (n = 102) were unvaccinated including 11 infants (≤ 1 year) not yet eligible for vaccination. The main route of transmission was nosocomial; at least six healthcare facilities and 41 healthcare workers and support personnel were affected. Sequencing of the viral nucleoprotein C-terminus (N450) identified genotype B3, belonging to the circulating MVs/Dublin.IRL/8.16-variant. Control measures were implemented, and the outbreak was contained in July 2018. The outbreak highlighted that raising awareness about measles and improving the vaccination coverage in under-vaccinated subgroups and personnel of healthcare facilities are key measures for prevention of future outbreaks.

Identifiants

pubmed: 37103785
doi: 10.2807/1560-7917.ES.2023.28.17.2200634
pmc: PMC10283469
doi:

Substances chimiques

Measles Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2019 Jul;24(29):
pubmed: 31339098
Euro Surveill. 2016;21(9):30152
pubmed: 26967661
Euro Surveill. 2019 Apr;24(17):
pubmed: 31039835
Euro Surveill. 2017 Apr 27;22(17):
pubmed: 28488998
Euro Surveill. 2018 May;23(20):
pubmed: 29790461
Wkly Epidemiol Rec. 2015 Jul 24;90(30):373-80
pubmed: 26211016
Vaccine. 2021 Sep 7;39(38):5346-5350
pubmed: 34393016
Am J Infect Control. 2013 Jul;41(7):661-3
pubmed: 23352075
J Med Virol. 2005 Jan;75(1):137-46
pubmed: 15543577
PLoS One. 2018 Jul 16;13(7):e0199975
pubmed: 30011283
Semergen. 2020 Mar;46(2):77-80
pubmed: 32061460
J Hosp Infect. 2018 Dec;100(4):e261-e263
pubmed: 29902487
Viruses. 2021 Oct 02;13(10):
pubmed: 34696412
Euro Surveill. 2015;20(39):
pubmed: 26537105
Eur J Clin Microbiol Infect Dis. 2022 Mar;41(3):455-466
pubmed: 34999974
Vaccine. 2012 Jun 8;30(27):3996-4001
pubmed: 22521843
J Infect Dis. 2016 Dec 15;214(12):1980-1986
pubmed: 27923955
Euro Surveill. 2019 Jan;24(3):
pubmed: 30670145
Euro Surveill. 2018 Jul;23(28):
pubmed: 30017024
Euro Surveill. 2011 Jul 21;16(29):
pubmed: 21801692
Enferm Infecc Microbiol Clin. 2010 Feb;28(2):73-4
pubmed: 20096973
Hum Vaccin Immunother. 2017 May 4;13(5):1078-1083
pubmed: 28059628
Clin Infect Dis. 2018 Oct 15;67(9):1315-1319
pubmed: 29878209
Euro Surveill. 2017 Aug 17;22(33):
pubmed: 28840827
Euro Surveill. 2017 Oct;22(42):
pubmed: 29067903
Rev Esp Salud Publica. 2015 Jul-Aug;89(4):365-79
pubmed: 26580792
PLoS One. 2013 Sep 10;8(9):e74754
pubmed: 24040337

Auteurs

Despina Pampaka (D)

National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Noemí López-Perea (N)

National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Aurora Fernández-García (A)

Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.

Isabel Huertas-Zarco (I)

Servei de Vigilància i Control Epidemiològic, Conselleria de Sanitat Universal i Salut Pública, Comunitat Valenciana, Valencia, Spain.

Maite Castellanos-Martínez (M)

Servei de Vigilància i Control Epidemiològic, Conselleria de Sanitat Universal i Salut Pública, Comunitat Valenciana, Valencia, Spain.

Katja Villatoro-Bongiorno (K)

Servei de Vigilància i Control Epidemiològic, Conselleria de Sanitat Universal i Salut Pública, Comunitat Valenciana, Valencia, Spain.

Javier Roig-Sena (J)

Servei de Vigilància i Control Epidemiològic, Conselleria de Sanitat Universal i Salut Pública, Comunitat Valenciana, Valencia, Spain.

Nuria Torner (N)

Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Universitat de Barcelona, Barcelona, Spain.

María Mar Mosquera (M)

Universitat de Barcelona, Barcelona, Spain.
Microbiology Department, Hospital Clínic de Barcelona, Barcelona, Spain.

Juan Emilio Echevarría (JE)

Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.

Joaquim Ferras Prats (JF)

Public Health Agency of Catalonia, Generalitat of Catalonia, Barcelona, Spain.

Josefa Masa-Calles (J)

National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH